The authors regret to have to make corrections in some of the affiliations of the contributing authors.
Acknowledgments
The authors would like to apologise for any inconvenience caused.
. Author manuscript; available in PMC: 2019 Aug 13.
Published in final edited form as: Oral Oncol. 2018 Sep 7;86:318. doi: 10.1016/j.oraloncology.2018.08.022
Corrigendum to “The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck” [Oral Oncol. 81 (2018) 100–108]
Vassiliki Saloura
a,*, Theodore Vougiouklakis
b, Kyunghee Burkitt
a, Yusuke Nakamura
b,c, Gordon L Hager
d, Carter van Waes
e
Vassiliki Saloura
aThoracic and Gastrointestinal Malignancies Branch, Center
for Cancer Research, National Cancer Institute, United States
Find articles by Vassiliki Saloura
Theodore Vougiouklakis
bDepartment of Medicine, University of Chicago, United
States
Find articles by Theodore Vougiouklakis
Kyunghee Burkitt
aThoracic and Gastrointestinal Malignancies Branch, Center
for Cancer Research, National Cancer Institute, United States
Find articles by Kyunghee Burkitt
Yusuke Nakamura
bDepartment of Medicine, University of Chicago, United
States
cDepartment of Surgery, University of Chicago, United
States
Find articles by Yusuke Nakamura
Gordon L Hager
dLaboratory of Receptor Biology and Gene Expression,
National Cancer Institute, United States
Find articles by Gordon L Hager
Carter van Waes
eHead and Neck Surgery Branch, National Institutes of
Deafness and Communication Disorders, United States
Find articles by Carter van Waes
aThoracic and Gastrointestinal Malignancies Branch, Center
for Cancer Research, National Cancer Institute, United States
bDepartment of Medicine, University of Chicago, United
States
cDepartment of Surgery, University of Chicago, United
States
dLaboratory of Receptor Biology and Gene Expression,
National Cancer Institute, United States
eHead and Neck Surgery Branch, National Institutes of
Deafness and Communication Disorders, United States
*
Corresponding author at: 41 Medlars Drive, National Cancer Institute, Bethesda, MD 20892, United States. vassiliki.saloura@nih.gov (V. Saloura).
Issue date 2018 Nov.
PMCID: PMC6691895 NIHMSID: NIHMS1040526 PMID: 30201513
The publisher's version of this article is available at Oral Oncol
This corrects the article "The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck" in volume 81 on page 100.